This exciting collaboration has led to the development of a drug targeted specifically to treat shingles. If it successfully passes through the last stage of trials, this drug has the capacity to improve the lives of the 2.5 million people worldwide who are afflicted by this debilitating condition each year.
Read more and watch a videoclip
Further Information:
Welsh School of PharmacyInhibitex